Suppr超能文献

口服普瑞巴林凝胶的细胞毒性表征与评价

Characterization and Evaluation of the Cytotoxicity of Pregabalin Gels for Oral Application.

作者信息

Xavier Gabriela Monteiro Barbosa, Ferreira Lindalva Maria de Meneses Costa, Passos Marcele Fonseca, Rodrigues Ana Paula Drummond, Franco Felipe Tuji de Castro, Silva Cecy Martins, Silva Júnior José Otávio Carréra, Ribeiro-Costa Roseane Maria, Araújo Jesuína Lamartine Nogueira

机构信息

School of Dentistry, Federal University of Pará, Belém 66075-110, PA, Brazil.

Laboratory of Pharmaceutical Nanotechnology, College of Pharmacy, Federal University of Pará, Belém 66075-110, PA, Brazil.

出版信息

Pharmaceuticals (Basel). 2024 Sep 4;17(9):1168. doi: 10.3390/ph17091168.

Abstract

The efficacy of pregabalin in pain treatment has led to the search for new formulations for its use through different routes of administration. This study aimed to prepare, characterize, and evaluate the cytotoxicity of pregabalin (PG) gels for topical application in the oral cavity. Solutions with three different concentrations of PG were prepared and added to a 1.0% carbopol gel base. Thermal analyses (TG and DSC) and FTIR were performed on the gel and pure pregabalin. Stability (preliminary and accelerated) and rheology studies were also conducted on the gels. Cytotoxicity was evaluated in human gingival fibroblasts in the following groups: WG (1.0% carbopol gel base), PG2G (2.0% pregabalin gel), PG5G (5.0% pregabalin gel), and PG10G (10% pregabalin gel). A transparent and homogeneous gel with a pH of 6 was obtained. The formulations showed stability, and the different drug concentrations did not influence the product's characteristics. None of the tested groups showed cytotoxicity for the analyzed cells. The pregabalin gels exhibited favorable and non-toxic characteristics for human gingival fibroblasts in vitro. Therefore, this product may be a promising therapeutic alternative for topical application in the oral mucosa.

摘要

普瑞巴林在疼痛治疗方面的疗效促使人们寻求通过不同给药途径使用它的新剂型。本研究旨在制备、表征和评估用于口腔局部应用的普瑞巴林(PG)凝胶的细胞毒性。制备了三种不同浓度PG的溶液,并将其添加到1.0%的卡波姆凝胶基质中。对凝胶和纯普瑞巴林进行了热分析(TG和DSC)以及傅里叶变换红外光谱(FTIR)分析。还对凝胶进行了稳定性(初步和加速)及流变学研究。在以下几组人牙龈成纤维细胞中评估细胞毒性:WG(1.0%卡波姆凝胶基质)、PG2G(2.0%普瑞巴林凝胶)、PG5G(5.0%普瑞巴林凝胶)和PG10G(10%普瑞巴林凝胶)。获得了一种pH值为6的透明均匀凝胶。这些制剂表现出稳定性,不同的药物浓度并未影响产品特性。所有测试组对所分析的细胞均未显示出细胞毒性。普瑞巴林凝胶在体外对人牙龈成纤维细胞表现出良好且无毒的特性。因此,该产品可能是口腔黏膜局部应用的一种有前景的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec93/11435025/2d329e1f5cc0/pharmaceuticals-17-01168-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验